Categories: News

Annual General Meeting in ALK-Abelló A/S held on 18 March 2021

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): ALK-Abelló A/S held its Annual General Meeting on 18 March 2021.

The Annual General Meeting transacted the following business:

  • Adoption of the annual report 2020 and discharge of the Board of Directors and Board of Management
  • No declaration of ordinary dividend
  • Adoption of the remuneration report for 2020
  • Adoption of the remuneration to the Board of Directors for the present year
  • Re-election of Anders Hedegaard as the Chairman of the Board of Directors
  • Re-election of Lene Skole as the Vice Chairman of the Board of Directors
  • Re-election of Lars Holmqvist, Jakob Riis and Vincent Warnery as well as new election of Gitte Aabo and Bertil Lindmark to the Board of Directors
  • Re-appointment of PwC Statsautoriseret Revisionspartnerselskab as the company’s auditor
  • Adoption of the following proposals from the Board of Directors:
    1. Authorisation for the Board to hold fully electronic general meetings
    2. Preparation etc. of corporate announcements and documents for internal use by the general meeting in English
    3. Indemnification of the Board of Directors and Board of Management
    4. Update of the remuneration policy

ALK-Abelló A/S


For further information please contact:
Anders Hedegaard, Chairman, tel. +45 4574 7576

Attachment

Staff

Recent Posts

Zepp Health Introduces Zepp OS 4: Redefining Wearable Intelligence by Integrating OpenAI’s GPT-4o into its Amazfit Smartwatches

Amazfit Active becomes the world's first smartwatch under €200 to fully-integrate AI. MILPITAS, Calif., July…

1 hour ago

Mission Therapeutics awarded $5.2m from The Michael J. Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325

Investment will support investigation of Mission's small molecule drug MTX325 in patients with early-stage Parkinson's…

1 hour ago

Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities

New report highlights challenges and opportunities in resilient MedTech industry LONDON, July 2, 2024 /PRNewswire/…

1 hour ago

Poolbeg Pharma PLC Announces Change of Registered Address

Change of Registered AddressLONDON, UK / ACCESSWIRE / July 2, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg'…

4 hours ago

IRLAB’s Phase IIb Study of Pirepemat Can Proceed as Planned after Positive Opinion from External Safety Committee

GOTHENBURG, SWEDEN / ACCESSWIRE / July 2, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, July…

4 hours ago